Amylyx shareholders elect Class I directors and ratify Deloitte as auditor at 2022 annual meeting

Amylyx Pharmaceuticals, Inc.

Justin Klee elected Class I director with 42,100,898 votes for, 1,607,476 withheld.
Isaac Cheng elected Class I director with 41,946,619 votes for, 1,761,755 withheld.
Ratification of Deloitte & Touche as independent auditor for FY2022 approved with 43,834,729 votes for, 72,090 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.